Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis

Clinical Hemorheology and Microcirculation

Volumn 21, Issue 1, 1999, Pages 1-6

  Martinez M ^a,b   Vaya, A ^a   Alvarino, J ^b   Barbera, J L ^c   Ramos, D ^a   Lopez A ^a   Aznar, J ^a  

^a Unidad de Hemorreölogia   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c Centra de Hemodiâlisis Gamapal   (Spain)

Author keywords

Hemodialysis; Hemorheology; Renal failure

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PLASMA VISCOSITY;

EID: 0032876579     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. C.A. Baldamus, K.M. Koch and W. Schoeppe, Biocompatibility in hemodialysis, Contributions to Nephrology 36 (1983), 1-139.
2. D. Bareford, O.E. Lucas, P.C.W. Stone, N.M. Caldwell, R. McGonigle and J. Stuart, Erythrocyte deformability in chronic renal failure, Clin. Hemorheol. 6 (1986), 501-510.
3. D. Docci, C. Del Veccio, P. Salvi et al., Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathy- roidism in urémie patients on maintenance hemodialysis, Clin. Nephrol. 23 (1985), 68-73.
4. E. Doerp, B. Hoidt, G. Körten et al., Hemorheology in relation to hemodialysis, in: 10 European Conference on Clinical Haemorlieology, Lisbon, C19 (Abstract), 1997.
5. S. Dorini, F. Marietta, R. Agosti et al., Macrorheologic pattern during chronic renal failure, in: 10 European Conference on. Clinical Haemorlieology, Lisbon, C16 (Abstract), 1997.
6. M. Duchesne-Gueguen, F. Durand, P. Le Pogam et al., Study of hemorheological parameters in patients with chronic renal failure and evolution of those parameters in the course of dialysis treatment, Clin. Hemorheol. 8 (1988), 407-414.
7. N.I. Gallagher, J.M. McCarthy, E.T. Hart and R.D. Lange, Evaluation of plasma erythropoietic-stimulating factors in anaemia urémie patients, Blood 14 (1959), 662.
8. J.C. Gris, B. Branger, F. Vecina, B. Sabadani, J. Fourcade and J.F. Schved, Increased vascular risk factors and features of endothelial activation and dysfunction in dialyzed urémie patients, Kidney Int. 46 (1994), 807-813.
9. Guidelines for measurement of blood viscosity and erythrocyte deformability. International Committee for standardization in Haematology. Expert panel on blood rheology, Clin. Hemorheol. 6 (1986), 439-453.
10. C. Haedersdal, J. Mehlsen, D. Stenver, B. Nielsen, L. Jeppesen and K. Winther, Erythropoietin treatment does not compromise cardiovascular function in chronic renal failure, Angiology 45 (1994), 231-234.
11. L. Houbouyan, J.F. Stoltz, A. Beauchet et al., Erythrocyte aggregation before and after haemodialysis, Nephron 70 (1995), 267-268.
12. L. Houbouyan, J.F. Stoltz, A. Beauchet, N. Consoli, J. Prinseau, A. Baglin and A. Goguel, Modifications de paramètres hemorheologiques au cours de l'hemodialyse chez l'insuffisant rénal chronique, J. Mal. Vase. 19 (1994), 132-136.
13. V. Inauen, N. Staubli, C. Descoeuvres, R.L. Galeazzi and P.W. Sträub, Erythrocyte deformability in dialysed urémie patients, Eiir. J. Clin. Invest. 12 (1982), 173-176.
14. W.B. Kännel, A.P. Wolf, W.P. Castelli and R.B. D'Agostino, Fibrinogen and risk of cardiovascular disease: The Framingham Study, JAMA 258 (1987), 1183-1186.
15. Y. Kikuchi, T. Koyama, Y. Koyama et al., Red blood cell deformability in renal failure, Nephron 30 (1982), 8-14.
16. S. Klahr, C. Schneider and I. Ichikawa, The progression of renal disease, New Engl. J. Med. 318 (1988), 1657-1666.
17. R. Koppensteiner, K. Derfler and H. Ehringer, Blood rheology after renal transplantation, Nephron 74 (1996), 328-332.
18. R. Koppensteiner, F. Stockenhuber, C. Jahn, P. Balcke, E. Minar and H. Ehringer, Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin, Br. Med. J. 300 (1990), 1626-1637.
19. TV. Kurtz, J.M. Slavirk and C.H. Hsu, Blood viscosity in experimental acute renal failure, Nephron 30 (1982), 348-351.
20. I.M. Meade, S. Mellows, M. Brozovic et al., Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study, Lancet ii, 533-537.
21. G.B. Nash, R.B. Wenby, S.O. Sowemino and H.J. Meiselman, Influence of cellular properties on red cell aggregation, Clin. Hemorheol. 7 (1987), 93-108.
22. F. Panicucci, A. Sagripanti and E. Pinori, Comprehensive study of haemostasis in chronic uremia, Nephron 33 (1993), 5-8.
23. V. Savica, G. Bellinghieri, C.M. Barbera, M. Egitto and F. Consolo, The coagulative system in haemodialyzed patients: the relationship between the elderly and hypertrygliceridemia, Arch. liai. Ural. Nefrol. Androl. 64 (1992), 155-63.
24. A.B. Schaw, Haemolysis in chronic renal failure, Br. Med. J. ii (1967), 213.
25. H. Schmid-Schönbein, P. Ruef and O. Linderkamp, The shear stress diffractometer Rheodyn SSD for determination of erythrocyte deformability. I. Principles of operation and reproducibility, Clin. Hemorheol. 16 (1996), 515-522.
26. N. Shusterman, P. Kimmel, F.L. Kiechle et al., Factors influencing erythrocyte sedimentation in patientes with chronic renal failure, Arch. Intern. Med. 145 (1985), 1796-1799.
27. M. Singh, Variation of blood viscosity and hematological parameters in renal failure, Indian J. Med. Set. 8 (1981), 175-178.
28. Z. Szikszai, S.G. Imre, L. Ujhelyi et al., Deformability and lipid pcroxidation of erythrocytes in hemodialysed patients, in: 10 European Conference on Clinical Haeniorlicology, Lisbon, CIS (Abstract), 1997.
29. S. Tamura, Y. Nakamura, M. Doi et al., Fibrinogcn, coagulation Factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factor in chronic hemodialysis and continous ambulatory peritoneal dialysis patients, Am. J. Kidney Dis. 27 (1996), 848-854.
30. S.G. Thompson, J.K. Kienast, S.D.M. Pyke, F. Haverkate and J.C.W. van de Loo, For the European concerted action on thrombosis and disabilities angina pectoris study group 1995 hamostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, New Engl. J. Mcd. 332 (1995), 635-641.
31. J. Traerger, Dossier insuffisance rénale chronique, Call. Med. 6 (1981), 1603-1636.
32. M.M. Udden, H.A. O'Rear, H. Kegel, L.V. Mclntire and R.C. Lynch, Decreased deformability of erythrocytes and increased intracellular calcium in patients with chronic renal failure, Clin. Hemorheol. 4 (1984), 473-481.
33. L. Wilhelmsen, K. Svardsudd, K. Korsan, B. Larsson, L. Welin and G. Tibblin, Fibrinogen as a risk factor for stroke and myocardial infarction, New Engl. J. Med. 311, 501-505.
34. J. Wink, N.D. Vaziri, S. Barker et al., The effect of hemodialysis on whole blood, plasma and erythrocyte viscosity, J. Artif. Organs 11 (1988), 340-342.
35. P. Zachee, M.H. Boogaerts, R.I. Lins, D.E. van den Broek and M.E. Broe, Erythrocyte deformability in urémie hemodialysed patients, Clin. Nephrol. 23 (1985), 315-318.